Servier India Pvt. Ltd. has launched a single-pill combination (SPC) of Bisoprolol/Perindopril in India under the brand name ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...

Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to safety concerns during a mid-stage trial, causing its shares to hit a record ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

With over 1 108 patients diagnosed with cancer each year, the designation of Manzini Government Hospital as a comprehensive cancer treatment centre brings hope to many. Prime Minister (PM) Russell ...

The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these ...

High blood pressure, or hypertension, is a common condition that increases the risk of heart disease, kidney problems, and ...

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia ...

The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...

The combination of belzutifan and cabozantinib has demonstrated “promising” antitumor activity in treatment-naive patients with advanced clear-cell RCC, according to researchers.